MEET QPS AT THE WORLDSymposium™ 2024; February 4 - 9, SAN DIEGO, CALIFORNIA, USA

Mitochondrial Membrane Depolarization (JC-1)

Mitochondrial Membrane Depolarization (JC-1)

Differentiated SH-SY5Y human neuroblastoma cells were lesioned with the Calcium ionophore ionomycin or with MPP+. Lesions were examined with JC-1 for mitochondrial membrane depolarization and with the MTT assay for cell viability in 96-well plates. JC-1 labelling was determined in a 96-well fluorescence plate reader with the appropriate filter settings. The ratio of red/green fluorescence in control cells was set to 100%. Compounds can be examined for their ability to counteract mitochondrial membrane depolarization induced by selected lesion agents.

Mitochondria-related-assays-figure2

Figure: Effect of ionomycin and MPP+ on mitochondrial membrane depolarization by JC-1 labeling. Images indicate control cells and cells lesioned with ionomycin or MPP+ for 3 hours. In intact mitochondria, JC-1 forms red fluorescent aggregates, whereas green fluorescent monomers indicate mitochondria with depolarized membrane potential.

Remark: These assays can also be customized for primary neurons.

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE

Biobank

QPS Neuropharmacology's well characterized and validated in vivo models are useful tools to push your CNS drug discovery research forward. We are happy to support your research activities with sample material from our biobank composed of various specimen derived from our in-house in vivo models.
LEARN MORE

animal models

QPS Neuropharmacology is highly experienced in generating, characterizing, and maintaining transgenic disease models and using them for drug testing projects for more than 20 years.
LEARN MORE

behavioral testing

QPS Neuropharmacology provides a wide range of behavioral tests for various indications. Most tests are evaluated using rater-independent digital animal tracking systems.
LEARN MORE

histology services

QPS Neuropharmacology offers a full set of histology services ranging from collection of tissue samples to delivering study reports that contain all experimental procedures and their outcome.
LEARN MORE

biomarkers

QPS Neuropharmacology Department of Translational Medicine offers a selection of molecular biological methods for the investigation of various diseases. The unit supports in vitro and in vivo studies performed at QPS Austria.
LEARN MORE